Fund Management At Engine No. 1 LLC Bristol Myers Squibb CO Transaction History

Fund Management At Engine No. 1 LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $146,056 - $163,313	2,523 Added 9.22%	29,874 $1.73 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $99,578 - $110,566	1,563 Added 6.06%	27,351 $1.75 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $156,455 - $177,455	2,381 Added 10.17%	25,788 $1.79 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $196,880 - $233,133	2,875 Added 14.0%	23,407 $1.68 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $125 - $74,073	-964 Reduced 4.48%	20,532 $1.46 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $220,982 - $243,379	3,043 Added 16.49%	21,496 $1.66 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $1.13 Million - $1.36 Million	18,453 New	18,453 $1.35 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.